首页> 外文期刊>Current opinion in HIV and AIDS >Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.
【24h】

Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.

机译:与艾滋病毒相关的神经认知障碍的辅助性和长效纳米配方抗逆转录病毒疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

Antiretroviral therapy has improved the quality and duration of life for people living with HIV-1. A significant long-term comorbid illness is HIV-associated neurocognitive disorders. Symptoms, although reduced in severity, are common. Disease occurs, in part, through continued low-level viral replication, inducing secondary glial neuroinflammatory activities. Our recent works and those of others have seen disease attenuated in animal models through the use of adjunctive and long-acting reservoir-targeted nanoformulated antiretroviral therapy. The translation of these inventions from animals to humans is the focus of this review.
机译:抗逆转录病毒疗法改善了HIV-1感染者的生活质量和寿命。与艾滋病毒相关的神经认知障碍是一种长期的重大合并症。症状虽然严重程度有所降低,但很常见。疾病的发生部分是通过持续的低水平病毒复制,诱导继发的神经胶质神经炎活动。我们最近的工作和其他工作,已通过使用辅助性和长效储库靶向纳米制剂抗逆转录病毒疗法在动物模型中减轻了疾病。这些发明从动物到人类的翻译是本文的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号